Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/neurelis-announces-presentations-at-the-american-epilepsy-society-annual-meeting-302003072.html
https://www.prnewswire.com/news-releases/neurelis-secures-new-orange-book-listed-us-patent-for-valtoco-diazepam-nasal-spray-civ-301994890.html
https://www.prnewswire.com/news-releases/neurelis-inc-to-participate-in-the-6th-annual-evercore-isi-healthconx-conference-301990462.html
https://www.prnewswire.com/news-releases/neurelis-to-participate-in-11th-annual-sofies-journey-epilepsy-awareness-day-and-education-expo-at-disneyland-resort-301970794.html
https://www.prnewswire.com/news-releases/neurelis-to-present-analyses-of-valtoco-diazepam-nasal-spray-civ-at-the-52nd-child-neurology-society-annual-meeting-301946700.html
https://www.prnewswire.com/news-releases/neurelis-to-present-analyses-of-valtoco-diazepam-nasal-spray-civ-highlighting-effects-on-timing-of-seizures-at-the-35th-international-epilepsy-congress-301914197.html
https://www.prnewswire.com/news-releases/neurelis-announces-four-poster-presentations-at-the-75th-annual-meeting-of-the-american-academy-of-neurology-301806429.html
https://www.prnewswire.com/news-releases/neurelis-announces-first-healthy-subjects-dosed-in-investigational-study-of-nrl-1049-a-rho-kinase-rock-inhibitor-with-potential-to-treat-cerebral-cavernous-malformations-301780480.html
https://www.prnewswire.com/news-releases/neurelis-announces-filing-of-its-investigational-new-drug-application-for-nrl-1049-a-rho-kinase-rock-inhibitor-with-potential-to-treat-cerebral-cavernous-malformations-301716126.html